Concepts (42)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pleural Neoplasms | 2 | 2025 | 82 | 0.400 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2026 | 267 | 0.390 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2026 | 334 | 0.340 |
Why?
|
| Lung Neoplasms | 3 | 2026 | 1552 | 0.320 |
Why?
|
| GPI-Linked Proteins | 1 | 2024 | 105 | 0.210 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2023 | 32 | 0.200 |
Why?
|
| Mesothelioma | 1 | 2024 | 93 | 0.200 |
Why?
|
| Metabolic Syndrome | 1 | 2026 | 366 | 0.180 |
Why?
|
| Genetic Therapy | 1 | 2025 | 725 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 819 | 0.160 |
Why?
|
| Immunotherapy | 1 | 2024 | 760 | 0.150 |
Why?
|
| Health Behavior | 1 | 2022 | 390 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1624 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 905 | 0.110 |
Why?
|
| Neoplasms | 1 | 2026 | 2968 | 0.080 |
Why?
|
| Aged | 4 | 2026 | 21279 | 0.060 |
Why?
|
| SEER Program | 1 | 2026 | 216 | 0.060 |
Why?
|
| B7-H1 Antigen | 1 | 2024 | 132 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2023 | 394 | 0.050 |
Why?
|
| Cisplatin | 1 | 2023 | 289 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2026 | 578 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2025 | 636 | 0.040 |
Why?
|
| Middle Aged | 3 | 2026 | 28939 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 703 | 0.040 |
Why?
|
| Cytokines | 1 | 2026 | 1355 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2023 | 1333 | 0.040 |
Why?
|
| Male | 4 | 2026 | 65464 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 2323 | 0.040 |
Why?
|
| Female | 4 | 2026 | 71430 | 0.040 |
Why?
|
| Humans | 6 | 2026 | 132158 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3714 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2026 | 17763 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1350 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2022 | 916 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2026 | 6544 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2026 | 6924 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3858 | 0.020 |
Why?
|
| Risk Factors | 1 | 2026 | 11034 | 0.020 |
Why?
|
| United States | 1 | 2026 | 11867 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 13017 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 18397 | 0.020 |
Why?
|
| Animals | 1 | 2025 | 34288 | 0.010 |
Why?
|